Ercros (FRA:CRS1) Cyclically Adjusted Revenue per Share: €8.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CRS1 Ercros SA FRA:CRS1
74 GF Score
Price €3.47
GF Value €3.15
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Ercros Cyclically Adjusted Revenue per Share?

Ercros FRA:CRS1 -0.57% 74 Cyclically Adjusted Revenue per Share is €8.08 as of Jun. 2026. GuruFocus rates FRA:CRS1 with a GF Score™ of 74/100 and a GF Value™ of €3.15 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ercros's adjusted revenue per share for the three months ended in Jun. 2026 was €2.202. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €8.08 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ercros's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ercros was 7.40% per year. The lowest was 2.80% per year. And the median was 5.50% per year.

As of today (2026-08-05), Ercros's current stock price is €3.465. Ercros's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €8.08. Ercros's Cyclically Adjusted PS Ratio of today is 0.43.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ercros was 0.64. The lowest was 0.26. And the median was 0.43.


Ercros  (FRA:CRS1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ercros's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.465/8.08
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ercros was 0.64. The lowest was 0.26. And the median was 0.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ercros Cyclically Adjusted Revenue per Share Related Terms


Ercros Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ercros's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ercros Cyclically Adjusted Revenue per Share Chart

Ercros Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.52 7.18 7.56 7.71 7.97

Ercros Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.84 7.88 7.97 8.04 8.08

FRA:CRS1 vs DOW: Cyclically Adjusted Revenue per Share Comparison

For the Chemicals subindustry, Ercros's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ercros Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ercros's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ercros's Cyclically Adjusted PS Ratio falls into.


FRA:CRS1
74GF Score
Ercros SA FRA:CRS1
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ercros Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ercros's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.202/131.3300*131.3300
=2.202

Current CPI (Jun. 2026) = 131.3300.

Ercros Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.282 99.737 1.688
201612 1.244 101.842 1.604
201703 1.556 100.896 2.025
201706 1.608 101.848 2.073
201709 1.493 101.524 1.931
201712 1.457 102.975 1.858
201803 1.526 102.122 1.962
201806 1.721 104.165 2.170
201809 1.540 103.818 1.948
201812 1.476 104.193 1.860
201903 1.642 103.488 2.084
201906 1.779 104.612 2.233
201909 1.580 103.905 1.997
201912 1.378 105.015 1.723
202003 1.470 103.469 1.866
202006 1.394 104.254 1.756
202009 1.364 103.521 1.730
202012 1.396 104.456 1.755
202103 1.731 104.857 2.168
202106 1.985 107.102 2.434
202109 2.009 107.669 2.450
202112 2.040 111.298 2.407
202203 2.673 115.153 3.049
202206 2.790 118.044 3.104
202209 2.655 117.221 2.975
202212 2.156 117.650 2.407
202303 2.375 118.948 2.622
202306 2.302 120.278 2.514
202309 1.708 121.343 1.849
202312 1.339 121.300 1.450
202403 1.997 122.762 2.136
202406 1.833 124.409 1.935
202409 1.699 123.121 1.812
202412 1.405 124.753 1.479
202503 1.953 125.531 2.043
202506 1.832 127.251 1.891
202509 1.598 126.840 1.655
202512 1.216 128.400 1.244
202603 1.642 129.860 1.661
202606 2.202 131.330 2.202

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €8.08 mean?
Ercros (FRA:CRS1) has a Cyclically Adjusted Revenue per Share of €8.08 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ercros and its competitors.
Is Ercros' Cyclically Adjusted Revenue per Share too high?
Ercros' current Cyclically Adjusted Revenue per Share is €8.08. Overall, Ercros has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ercros' Cyclically Adjusted Revenue per Share compare to DOW?
Ercros' Cyclically Adjusted Revenue per Share of €8.08 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ercros and its competitors. Ercros's current Cyclically Adjusted Revenue per Share is €8.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ercros stock overvalued right now?
Based on GuruFocus' analysis, Ercros (FRA:CRS1) is currently considered Fairly Valued. The stock's GF Value™ is €3.15, compared to a current price of €3.47 — trading 10% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €8.08. Ercros' overall GF Score™ is 74/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ercros (FRA:CRS1), the current Cyclically Adjusted Revenue per Share is €8.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ercros (FRA:CRS1) Overvalued in 2026?

Based on GuruFocus' analysis, Ercros stock appears to be overvalued. The current stock price of €3.47 is trading 10% above its estimated GF Value™ of €3.15. GuruFocus considers Ercros to be Fairly Valued.

Key valuation signals for FRA:CRS1:

  • Cyclically Adjusted Revenue per Share: €8.08
  • GF Value™: €3.15 vs. price of €3.47 (10% above fair value)
  • GF Score™: 74/100 with 8 warning signs

No single metric tells the full story. See the FRA:CRS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ercros Business Description

Other Exchanges 0M0E:UKECR:Spain
Address Avinguda Diagonal, 593-595, Barcelona, ESP, 08014
Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.
74GF Score

Get the complete analysis for FRA:CRS1

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.47
Price
€3.15
GF Value